A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus.

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the ...

Coronavirus J&J COVID-19 vaccine benefits ‘far outweigh’ risks, CDC panel says after reports of Guillain-Barré syndrome Researchers noted a reporting rate of 8.1 GBS cases per million J&J ...

A new international study analysing data from over 230 million people across 20 global sites highlights the relationship between SARS-CoV-2 infection, certain Covid-19 vaccines, and Guillain-Barré ...

If you get Covid-19, your chances of dying are much higher. ... While Guillain-Barre is a tragic side effect, it is incredibly rare and it shouldn’t change your current vaccination policies.

Reference: Nasreen S, Jiang Y, Lu H, et al. Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study. Vaccine.

The odds of developing Guillain-Barré syndrome after getting the COVID-19 shot, they say, are less than getting it from other vaccines, bacteria and viruses, including SARS-CoV-2, the virus that ...

Two studies published in Annals of Neurology reported small clusters “of an unusual variant of Guillain-Barre syndrome” following receipt of a COVID-19 vaccine, according to a press release ...

Sept. 24 (UPI) --People with COVID-19 may be at increased risk for developing Guillain-Barre syndrome, a study published Friday by the journal Brain found. Eleven of 49 patients with the rare ...

Johnson & Johnson’s beleaguered Covid-19 vaccine may be associated with a small increased risk of Guillain–Barré syndrome, a rare but potentially serious neurological condition, federal ...

Johnson & Johnson’s beleaguered Covid-19 vaccine may be associated with a small increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition, federal ...

About 3,000 people are diagnosed with Guillain-Barre Syndrome every year in the U.S. Last fall, U.K. scientists studied the links between the disorder and COVID-19 and found no increases in ...